Circular RNAs Regulate Glucose Metabolism in Cancer Cells

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2021 Jul 9

PMID 34239306

Citations 5

Authors

Xiaoyu Ji

Wei Sun

Chengzhou Lv

Jiapeng Huang

Hao Zhang

Affiliations

Soon will be listed here.

Abstract

Circular RNAs (circRNAs) were originally thought to result from RNA splicing errors. However, it has been shown that circRNAs can regulate cancer onset and progression in various ways. They can regulate cancer cell proliferation, differentiation, invasion, and metastasis. Moreover, they modulate glucose metabolism in cancer cells through different mechanisms such as directly regulating glycolytic enzymes and glucose transporter (GLUT) or indirectly regulating signal transduction pathways. In this review, we elucidate on the role of circRNAs in regulating glucose metabolism in cancer cells, which partly explains the pathogenesis of malignant tumors, and provides new therapeutic targets or new diagnostic and prognostic markers for human cancers.

Citing Articles

CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD/NAMPT Metabolism Axis.

Li H, Xu H, Liu M, Li Y, Yuan S, Yin P Mol Biotechnol. 2024; .

PMID: 38951482 DOI: 10.1007/s12033-024-01226-2.

Unraveling the crosstalk: circRNAs and the wnt signaling pathway in cancers of the digestive system.

Zhang Y, Zhang C, Peng C, Jia J Noncoding RNA Res. 2024; 9(3):853-864.

PMID: 38586314 PMC: 10995981. DOI: 10.1016/j.ncrna.2024.03.004.

Research progress of circRNA in malignant tumour metabolic reprogramming.

Geng Y, Wang M, Wu Z, Jia J, Yang T, Yu L RNA Biol. 2023; 20(1):641-651.

PMID: 37599427 PMC: 10443989. DOI: 10.1080/15476286.2023.2247877.

Non-coding RNAs in breast cancer: with a focus on glucose metabolism reprogramming.

Liang J, Ye C, Chen K, Gao Z, Lu F, Wei K Discov Oncol. 2023; 14(1):72.

PMID: 37204526 PMC: 10199155. DOI: 10.1007/s12672-023-00687-2.

A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma.

Yang H, Zhang M, Sun H, Chai Y, Li X, Jiang Q Front Oncol. 2021; 11:783194.

PMID: 34869036 PMC: 8636331. DOI: 10.3389/fonc.2021.783194.

References

Liang F, Li Q, Li X, Li Z, Gong Z, Deng H . TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. Int J Oncol. 2016; 49(3):1046-56. DOI: 10.3892/ijo.2016.3599. View

Dang C, Le A, Gao P . MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009; 15(21):6479-83. PMC: 2783410. DOI: 10.1158/1078-0432.CCR-09-0889. View

Hussien R, Brooks G . Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics. 2010; 43(5):255-64. PMC: 3068517. DOI: 10.1152/physiolgenomics.00177.2010. View

Liu W, Yin C, Liu Y . Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm. 2020; 36(10):863-878. DOI: 10.1089/cbr.2019.3472. View

Gudi R, Kedishvili N, Zhao Y, Popov K . Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 1995; 270(48):28989-94. DOI: 10.1074/jbc.270.48.28989. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Li Y, Zang H, Zhang X, Huang G . Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis. Cancer Manag Res. 2020; 12:7739-7751. PMC: 7473989. DOI: 10.2147/CMAR.S259424. View

Warburg O . THE CHEMICAL CONSTITUTION OF RESPIRATION FERMENT. Science. 1928; 68(1767):437-43. DOI: 10.1126/science.68.1767.437. View

Li Q, Chen P, Zeng Z, Liang F, Song Y, Xiong F . Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. Tumour Biol. 2016; 37(9):12503-12512. DOI: 10.1007/s13277-016-5113-z. View

10.

Borran S, Ahmadi G, Rezaei S, Anari M, Modabberi M, Azarash Z . Circular RNAs: New players in thyroid cancer. Pathol Res Pract. 2020; 216(10):153217. DOI: 10.1016/j.prp.2020.153217. View

11.

Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

12.

Chan D, Sutphin P, Nguyen P, Turcotte S, Lai E, Banh A . Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011; 3(94):94ra70. PMC: 3683134. DOI: 10.1126/scitranslmed.3002394. View

13.

Fang X, Bai Y, Zhang L, Ding S . Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia. Biosci Rep. 2020; 40(6). PMC: 7313448. DOI: 10.1042/BSR20201275. View

14.

Capello M, Ferri-Borgogno S, Riganti C, Chattaragada M, Principe M, Roux C . Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget. 2016; 7(5):5598-612. PMC: 4868708. DOI: 10.18632/oncotarget.6798. View

15.

Agren R, Mardinoglu A, Asplund A, Kampf C, Uhlen M, Nielsen J . Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol. 2014; 10:721. PMC: 4017677. DOI: 10.1002/msb.145122. View

16.

Li Y, Zang H, Zhang X, Huang G . circ_0136666 Facilitates the Progression of Colorectal Cancer via miR-383/CREB1 Axis. Cancer Manag Res. 2020; 12:6795-6806. PMC: 7424319. DOI: 10.2147/CMAR.S251952. View

17.

Masui K, Tanaka K, Akhavan D, Babic I, Gini B, Matsutani T . mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013; 18(5):726-39. PMC: 3840163. DOI: 10.1016/j.cmet.2013.09.013. View

18.

Chen W, Li Y, Zhong J, Wen G . circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Mol Med Rep. 2021; 23(6). PMC: 8097765. DOI: 10.3892/mmr.2021.12103. View

19.

van Dam E, Govers R, James D . Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol Endocrinol. 2005; 19(4):1067-77. DOI: 10.1210/me.2004-0413. View

20.

Li Z, Huang C, Bao C, Chen L, Lin M, Wang X . Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015; 22(3):256-64. DOI: 10.1038/nsmb.2959. View